{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:32:42Z","timestamp":1794576762907,"version":"4.9.1"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.critrevonc.2026.105234","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T23:10:38Z","timestamp":1772320238000},"page":"105234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Interplay between exosomes and the PD-1\/PD-L1 axis in hepatocellular carcinoma: Implications for immune escape and immunotherapy"],"prefix":"10.1016","volume":"222","author":[{"given":"Minghao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105234_bib1","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries","volume":"6","author":"Zeng","year":"2018","journal-title":"Lancet Glob. Heal"},{"key":"10.1016\/j.critrevonc.2026.105234_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4254\/wjh.v14.i2.354","article-title":"Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: can we stratify at-risk populations?","volume":"14","author":"Fassio","year":"2022","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/jir.2022.0172","article-title":"Analysis of immune and inflammatory microenvironment characteristics of noncancer end-stage liver disease","volume":"43","author":"Wang","year":"2023","journal-title":"J. Inter. Cytokine Res J. Int Soc. Inter. Cytokine Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","article-title":"Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy","volume":"22","author":"Seyhan","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1581398","article-title":"PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1","volume":"16","author":"Peng","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030854","article-title":"Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma","volume":"15","author":"Chiang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105234_bib7","first-page":"228","article-title":"Exosomes: intriguing mediators of intercellular communication in the organism\u2019s response to noxious agents","volume":"75","author":"Vu\u010demilovi\u0107","year":"2024","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41423-025-01323-5","article-title":"The role of exosomes in immunopathology and potential therapeutic implications","volume":"22","author":"Wang","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12967-025-06814-7","article-title":"Tumor-derived exosomes and their application in cancer treatment","volume":"23","author":"Javdani-Mallak","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib10","doi-asserted-by":"crossref","first-page":"11373","DOI":"10.18632\/aging.206020","article-title":"High expression of circulating exosomal PD-L1 contributes to immune escape of hepatocellular carcinoma and immune clearance of chronic hepatitis B","volume":"16","author":"Lin","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105234_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ags3.12772","article-title":"Exosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant progression by modulating the miR-514a-3p\/PD-L1 pathway","volume":"8","author":"Dou","year":"2024","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.critrevonc.2026.105234_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189334","article-title":"PD-1\/PD-L1 blockade therapy in hepatocellular carcinoma: current status and potential biomarkers","author":"Xu","year":"2025","journal-title":"Biochim Biophys Acta (BBA)Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.569219","article-title":"Exosomal PD-L1: new insights into tumor immune escape mechanisms and therapeutic strategies","volume":"8","author":"Zhou","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jnt3010005","article-title":"Exosomes for regulation of immune responses and immunotherapy","volume":"3","author":"Hussain","year":"2022","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.critrevonc.2026.105234_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14164036","article-title":"Role of exosomes in immunotherapy of hepatocellular carcinoma","volume":"14","author":"Tian","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105234_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2026.105234_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41416-019-0466-x","article-title":"Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study","volume":"120","author":"Pinato","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.989190","article-title":"Dynamic alterations in PD-1\/PD-L1 expression level and immune cell profiles based on radiation response status in mouse tumor model","volume":"12","author":"Yoon","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib19","first-page":"2079","article-title":"Expression and clinical significance of PD\u20111 in hepatocellular carcinoma tissues detected by a novel mouse anti-human PD\u20111 monoclonal antibody","volume":"52","author":"Li","year":"2018","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115644","article-title":"Current progress, strategy, and prospects of PD-1\/PDL-1 immune checkpoint biosensing platforms for cancer diagnostics, therapy monitoring, and drug screening","volume":"240","author":"Ratajczak","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.critrevonc.2026.105234_bib21","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fimmu.2023.1296857","article-title":"Recent advances in exosome-based immunotherapy applied to cancer","volume":"14","author":"Xie","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1603855","article-title":"Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy","volume":"16","author":"Kansha","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43556-025-00280-9","article-title":"Exosomes in inflammation and cancer: from bench to bedside applications","volume":"6","author":"Huang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.critrevonc.2026.105234_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109288","article-title":"Extracellular vesicles and particles impact the systemic landscape of cancer","volume":"41","author":"Lucotti","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.critrevonc.2026.105234_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107751","article-title":"Extracellular vesicles as nature\u2019s nano carriers in cancer therapy: Insights toward preclinical studies and clinical applications","volume":"217","author":"Wu","year":"2025","journal-title":"Pharm. Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib26","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1002\/jcp.30197","article-title":"Tumor-derived exosomes in the PD-1\/PD-L1 axis: significant regulators as well as promising clinical targets","volume":"236","author":"Liang","year":"2021","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib27","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cbin.12225","article-title":"AML cell-derived exosomes suppress the activation and cytotoxicity of NK cells in AML via PD-1\/PD-L1 pathway","volume":"48","author":"Wang","year":"2024","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.critrevonc.2026.105234_bib28","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1245\/s10434-019-07431-7","article-title":"Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis","volume":"26","author":"Fan","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12964-021-00810-2","article-title":"Endoplasmic reticulum stress promotes the release of exosomal PD-L1 from head and neck cancer cells and facilitates M2 macrophage polarization","volume":"20","author":"Yuan","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.critrevonc.2026.105234_bib30","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.critrevonc.2026.105234_bib31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.32387","article-title":"Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression","volume":"76","author":"Luo","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653808","article-title":"LncRNA KCNQ1OT1 secreted by tumor cell-derived exosomes mediates immune escape in colorectal cancer by regulating PD-L1 ubiquitination via MiR-30a-5p\/USP22","volume":"9","author":"Xian","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12032-023-02093-8","article-title":"Exosomal PIK3CB promotes PD-L1 expression and malignant transformation in esophageal squamous cell carcinoma","volume":"40","author":"Xu","year":"2023","journal-title":"Med Oncol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2057837","article-title":"Myeloma-derived IL-32\u03b3 induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/10815589231207801","article-title":"Integrin \u03b12 promotes immune escape in non-small-cell lung cancer by enhancing PD-L1 expression in exosomes to inhibit CD8 + T-cell activity","volume":"72","author":"Jing","year":"2023","journal-title":"J. Invest. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41419-024-07191-7","article-title":"PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105234_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib38","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1111\/cas.15433","article-title":"Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+ T-cell activity and promotes immune escape","volume":"113","author":"Yang","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105234_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001372","article-title":"Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1\u2013mediated immunoescape via STING-IFN signaling and extracellular vesicles","volume":"8","author":"Cheng","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib40","article-title":"Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages","volume":"9","author":"Yin","year":"2022","journal-title":"Adv. Sci. (Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.critrevonc.2026.105234_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113261","article-title":"Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN\/AKT\/NF-\u03baB\/PD-L1 pathway","volume":"143","author":"Wu","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib42","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1007\/s10620-024-08536-0","article-title":"Regulation of the PD-1\/PD-L1 axis and NK cell dysfunction by exosomal miR-552-5p in gastric cancer","volume":"69","author":"Tang","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.critrevonc.2026.105234_bib43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cas.16036","article-title":"Cancer cell-derived exosomal miR-20a-5p inhibits CD8(+) T-cell function and confers anti-programmed cell death 1 therapy resistance in triple-negative breast cancer","volume":"115","author":"Li","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105234_bib44","doi-asserted-by":"crossref","DOI":"10.2174\/0113862073367894250925093658","article-title":"Zuojinwan antagonizes drug resistance transmission of gastric cancer induced by hypoxia through exosomal Mir-30a mediated hedgehog\/ PD-L1 signalling","author":"Wei","year":"2025","journal-title":"Comb. Chem. High. Throughput Screen"},{"key":"10.1016\/j.critrevonc.2026.105234_bib45","article-title":"LncRNA BCCE4 genetically enhances the PD-L1\/PD-1 interaction in smoking-related bladder cancer by modulating miR-328-3p-USP18 signaling","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.critrevonc.2026.105234_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbrc.2023.01.005","article-title":"Exosomal lncRNA HOTAIR induces PDL1(+) B cells to impede anti-tumor immunity in colorectal cancer","volume":"644","author":"Xie","year":"2023","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.critrevonc.2026.105234_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/1541-7786.MCR-23-0282","article-title":"Exosomal lncRNA NEAT1 inhibits NK-cell activity to promote multiple myeloma cell immune escape via an EZH2\/PBX1 axis","volume":"22","author":"Wang","year":"2024","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12935-022-02741-5","article-title":"Exosomal LINC00460\/miR-503-5p\/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell-mediated cytotoxicity and PD-1 checkpoint","volume":"22","author":"Yao","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2026.105234_bib49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ncrna.2024.10.005","article-title":"Glycolysis regulated exosomal LINC01214 inhibited CD8(+) T cell function and induced anti-PD1 resistance in melanoma via modulating miR-4492\/PPP1R11 axis","volume":"10","author":"Ding","year":"2025","journal-title":"NonCoding RNA Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molimm.2021.10.002","article-title":"Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1\/ miR-142-5p\/ PD-L1 axis","volume":"140","author":"Jiang","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110868","article-title":"Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression","volume":"124","author":"Du","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13046-022-02505-z","article-title":"Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1","volume":"41","author":"Gao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112742","article-title":"M2 macrophage exosomal HOXC13-AS in laryngeal cancer immunity via targeting miR-485-5p\/IGF2BP2\/PD-L1","volume":"140","author":"He","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13046-024-03050-7","article-title":"Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM\/PD-L1 signaling","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib55","article-title":"Exosomal CMTM4 induces immunosuppressive macrophages to promote ovarian cancer progression and attenuate Anti-PD-1 immunotherapy","volume":"12","author":"Yin","year":"2025","journal-title":"Adv. Sci. (Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.critrevonc.2026.105234_bib56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cei\/uxac102","article-title":"Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3","volume":"210","author":"Wu","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10142-024-01447-3","article-title":"The mechanism of MMP14-positive tumor-associated fibroblast subsets in inhibiting PD-1 immunotherapy for esophageal cancer through exosomal tsRNA-10522","volume":"24","author":"Wang","year":"2024","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.critrevonc.2026.105234_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004043","article-title":"Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents","volume":"10","author":"Turiello","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2020.12.012","article-title":"Exosomal O-GlcNAc transferase from esophageal carcinoma stem cell promotes cancer immunosuppression through up-regulation of PD-1 in CD8(+) T cells","volume":"500","author":"Yuan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105234_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101576","article-title":"Role of breast cancer-derived exosomes in metabolism of immune cells through PD1-GLUT1-HK2 metabolic axis","volume":"71","author":"Joudaki","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.critrevonc.2026.105234_bib61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3892\/etm.2023.11785","article-title":"Exosomes derived from MDR cells induce cetuximab resistance in CRC via PI3K\/AKT signaling\u2011mediated Sox2 and PD\u2011L1 expression","volume":"25","author":"Wei","year":"2023","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib62","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/s12276-024-01340-w","article-title":"Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics","volume":"56","author":"Ye","year":"2024","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.12.010","article-title":"Extracellular vesicles in anti-tumor drug resistance: mechanisms and therapeutic prospects","volume":"14","author":"Cheng","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.critrevonc.2026.105234_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147177","article-title":"Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1\/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer","volume":"857","author":"Hisakane","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2026.105234_bib65","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1002\/cam4.4638","article-title":"Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression","volume":"11","author":"Chen","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1158\/2326-6066.CIR-22-0277","article-title":"HRS regulates small extracellular vesicle PD-L1 secretion and is associated with Anti\u2013PD-1 treatment efficacy","volume":"11","author":"Xiao","year":"2023","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib67","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00262-021-03138-5","article-title":"Enhancing the anti-leukemia immunity of acute lymphocytic leukemia-derived exosome-based vaccine by downregulation of PD-L1 expression","volume":"71","author":"Huang","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105234_bib68","article-title":"MFGE8 induces anti-PD-1 therapy resistance by promoting extracellular vesicle sorting of PD-L1","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib69","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-024-02099-4","article-title":"LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer","volume":"23","author":"Wu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib70","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ymthe.2021.03.013","article-title":"Inhibition of xCT suppresses the efficacy of anti-PD-1\/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization","volume":"29","author":"Liu","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105234_bib71","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1038\/s41388-021-01896-1","article-title":"Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer","volume":"40","author":"Qiu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105234_bib72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00262-024-03785-4","article-title":"The expression of PD-L1 on tumor-derived exosomes enhances infiltration and anti-tumor activity of \u03b1CD3\u2009\u00d7\u2009\u03b1PD-L1 bispecific antibody-armed T cells","volume":"73","author":"Cho","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105234_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2023.110646","article-title":"Exosomes-delivered PD-L1 siRNA and CTLA-4 siRNA protect against growth and tumor immune escape in colorectal cancer","volume":"115","author":"Li","year":"2023","journal-title":"Genomics"},{"key":"10.1016\/j.critrevonc.2026.105234_bib74","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1038\/s41598-021-87575-3","article-title":"Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer","volume":"11","author":"Shimada","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105234_bib75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/cac2.70016","article-title":"Blocking ITGA5 potentiates the efficacy of anti-PD-1 therapy on glioblastoma by remodeling tumor-associated macrophages","volume":"45","author":"Zhao","year":"2025","journal-title":"Cancer Commun (London England)"},{"key":"10.1016\/j.critrevonc.2026.105234_bib76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13287-025-04227-3","article-title":"Exosomal miR-125b-5p derived from mesenchymal stromal\/stem cell enhances anti-PD-1 therapy in mouse colon cancer model","volume":"16","author":"Jiang","year":"2025","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.critrevonc.2026.105234_bib77","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13886","article-title":"CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes","volume":"30","author":"Ning","year":"2023","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.critrevonc.2026.105234_bib78","article-title":"Exosomal PDL1 suppresses the anticancer activity of CD8(+) T cells in hepatocellular carcinoma","volume":"2024","author":"Hu","year":"2024","journal-title":"Anal Cell Pathol (Amst)"},{"key":"10.1016\/j.critrevonc.2026.105234_bib79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","article-title":"Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41392-021-00784-0","article-title":"GOLM1 exacerbates CD8(+) T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2026.105234_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143246","article-title":"Circular RNA CDYL facilitates hepatocellular carcinoma stemness and PD-L1+ exosomes-mediated immunotherapy resistance via stabilizing hornerin protein by blocking synoviolin 1-mediated ubiquitination","volume":"310","author":"Fu","year":"2025","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib82","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/HEP.0000000000001244","article-title":"Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma","volume":"82","author":"Cheng","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib83","first-page":"2021","article-title":"Exosome CTLA-4 regulates PTEN\/CD44 signal pathway in spleen deficiency internal environment to promote invasion and metastasis of hepatocellular carcinoma","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.critrevonc.2026.105234_bib84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21010\/ajtcam.v14i1.18","article-title":"Establishment and evaluation of orthotopic hepatocellular carcinoma and drug-induced hepatocellular carcinoma in mice with spleen-deficiency syndrome in traditional chinese medicine","volume":"14","author":"Luo","year":"2017","journal-title":"Afr. J. Tradit. Complement Alter. Med AJTCAM"},{"key":"10.1016\/j.critrevonc.2026.105234_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1679934","article-title":"Cancer-derived exosomes: mediators of immune crosstalk and emerging targets for immunotherapy","volume":"16","author":"Mahamed","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12964-021-00816-w","article-title":"Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies","volume":"20","author":"Liu","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.critrevonc.2026.105234_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15092365","article-title":"Exosome cargos as biomarkers for diagnosis and prognosis of hepatocellular carcinoma","volume":"15","author":"Zeng","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2026.105234_bib88","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4274\/balkanmedj.galenos.2025.2025-1-129","article-title":"Potential roles of serum exosomal CD155 and its impact on NK cell immunosuppression in hepatocellular carcinoma","volume":"42","author":"Han","year":"2025","journal-title":"Balk. Med J."},{"key":"10.1016\/j.critrevonc.2026.105234_bib89","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/cancers13020164","article-title":"PD-L1\/PD-1 axis in multiple myeloma microenvironment and a possible link with CD38-mediated immune-suppression","volume":"13","author":"Costa","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105234_bib90","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2152635","article-title":"Overcoming the resistance of hepatocellular carcinoma to PD-1\/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles","volume":"12","author":"Deng","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib91","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s12276-025-01465-6","article-title":"Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation","volume":"57","author":"Lv","year":"2025","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib92","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/08820139.2024.2445608","article-title":"NK cell exosomes alleviate PD-L1 expression and facilitate tumor immunity by repressing PI3K-AKT-mTOR signaling","volume":"54","author":"Xie","year":"2025","journal-title":"Immunol. Invest"},{"key":"10.1016\/j.critrevonc.2026.105234_bib93","article-title":"Mechanism of M2 type macrophage-derived extracellular vesicles regulating PD-L1 expression via the MISP\/IQGAP1 axis in hepatocellular carcinoma immunotherapy resistance","volume":"124","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib94","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1007\/s00262-023-03525-0","article-title":"Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma","volume":"72","author":"Chang","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105234_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.900155","article-title":"Crosstalk of exosomal non-coding RNAs in the tumor microenvironment: novel frontiers","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib96","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/imm.13853","article-title":"Hypoxic tumour-derived exosomal miR-1290 exacerbates the suppression of CD8+ T cells by promoting M2 macrophage polarization","volume":"173","author":"Yang","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib97","article-title":"Cancer cell-derived exosomal miR-500a-3p modulates hepatic stellate cell activation and the immunosuppressive microenvironment","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.critrevonc.2026.105234_bib98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5582\/bst.2022.01281","article-title":"Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474\u20133\u2009P-ALOX-15 and EMT axes","volume":"16","author":"Liu","year":"2022","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.critrevonc.2026.105234_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102125","article-title":"Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma","volume":"35","author":"Zhao","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2026.105234_bib100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1601479","article-title":"SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC","volume":"8","author":"Yin","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156750","article-title":"Oleanolic acid inhibits M2 macrophage polarization and potentiates anti-PD-1 therapy in hepatocellular carcinoma by targeting miR-130b-3p-PTEN-PI3K-Akt signaling and glycolysis","volume":"141","author":"Tu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.critrevonc.2026.105234_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1609165","article-title":"Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression","volume":"16","author":"Lai","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib103","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12072-020-10101-6","article-title":"Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma","volume":"15","author":"Fan","year":"2021","journal-title":"Hepatol. Int"},{"key":"10.1016\/j.critrevonc.2026.105234_bib104","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s41467-025-57367-8","article-title":"HBV-associated hepatocellular carcinomas inhibit antitumor CD8(+) T cell via the long noncoding RNA HDAC2-AS2","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105234_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112282","article-title":"Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape","volume":"138","author":"Shang","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib106","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","article-title":"Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib107","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12935-022-02784-8","article-title":"Intercellular crosstalk between cancer cells and cancer-associated fibroblasts via extracellular vesicles","volume":"22","author":"Naito","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2026.105234_bib108","first-page":"2","article-title":"Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment","volume":"8","author":"Xie","year":"2025","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.critrevonc.2026.105234_bib109","first-page":"950","article-title":"POSTN(+) CAF-derived migrasomes drive hepatocellular carcinoma progression and confer resistance to immunotherapy. Res (Washington, DC)","volume":"8","author":"Zhu","year":"2025"},{"key":"10.1016\/j.critrevonc.2026.105234_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23778","article-title":"Cancer-associated fibroblasts-derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD-L1","volume":"38","author":"Feng","year":"2024","journal-title":"J. Biochem Mol. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib111","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12943-024-02170-0","article-title":"Myofibroblast-derived extracellular vesicles facilitate cancer stemness of hepatocellular carcinoma via transferring ITGA5 to tumor cells","volume":"23","author":"Xiao","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105234_bib112","first-page":"257","article-title":"The dual role of exosomes in the tumor microenvironment: from pro-tumorigenic signaling to immune modulation","volume":"1","author":"Li","year":"2025","journal-title":"Med Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib113","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41419-021-04171-z","article-title":"Extracellular vesicles and immunogenic stress in cancer","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105234_bib114","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.30607","article-title":"Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and Up-regulate programmed death ligand 1 expression in macrophages","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib115","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1158\/2326-6066.CIR-23-0469","article-title":"Endoplasmic reticulum stress potentiates the immunosuppressive microenvironment in hepatocellular carcinoma by promoting the release of SNHG6-enriched small extracellular vesicles","volume":"12","author":"Liu","year":"2024","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib116","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s10753-024-02214-z","article-title":"Exosomes derived from endoplasmic reticulum stressed hepatocellular carcinoma cells enhance the antitumor immunity of dendritic cells","volume":"48","author":"Zhang","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.critrevonc.2026.105234_bib117","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s12951-025-03766-4","article-title":"Nanomedicine targeting the PD-1\/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance","volume":"23","author":"Xiang","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib118","first-page":"5333","article-title":"Exosomes derived from hepatocellular carcinoma inhibit CD4+ and CD8+ T cell function through the PD-1\/PD-L1 pathway","volume":"12","author":"Li","year":"2019","journal-title":"Int J. Clin. Exp. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib119","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/CJI.0000000000000496","article-title":"LOXL4 shuttled by tumor cells-derived extracellular vesicles promotes immune escape in hepatocellular carcinoma by activating the STAT1\/PD-L1 axis","volume":"47","author":"Zhao","year":"2024","journal-title":"J. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105234_bib120","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.7150\/thno.104557","article-title":"Tumor-derived exosomes induce neutrophil infiltration and reprogramming to promote T-cell exhaustion in hepatocellular carcinoma","volume":"15","author":"Bi","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105234_bib121","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41419-017-0180-7","article-title":"14-3-3\u03b6 delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105234_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109925","article-title":"Tumor cell-derived LC3B+extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90\u03b1-IL-6\/IL-8 signaling axis","volume":"261","author":"Chen","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176037","article-title":"Oroxylin a promoted apoptotic extracellular vesicles transfer of glycolytic kinases to remodel immune microenvironment in hepatocellular carcinoma model","volume":"957","author":"Wang","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105234_bib124","first-page":"132","article-title":"Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma","volume":"6","author":"Guan","year":"2022","journal-title":"Liver Res (Beijing China)"},{"key":"10.1016\/j.critrevonc.2026.105234_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108198","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong","year":"2024","journal-title":"Comput. Biol. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib126","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.dld.2025.03.022","article-title":"Exosomal CCT3 as a biomarker for diagnosis and immune therapy response in patients diagnosed with hepatocellular carcinoma","volume":"57","author":"Liu","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.critrevonc.2026.105234_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101651","article-title":"An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma","volume":"31","author":"Peng","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41392-021-00801-2","article-title":"An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity","volume":"6","author":"Wei","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2026.105234_bib129","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00262-021-03021-3","article-title":"Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection","volume":"71","author":"Chen","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105234_bib130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.28549","article-title":"Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro","volume":"64","author":"Rao","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib131","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1038\/s41598-025-93486-4","article-title":"Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma","volume":"15","author":"Guo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105234_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.01.010","article-title":"Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablation","volume":"14","author":"Ren","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.critrevonc.2026.105234_bib133","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7150\/ijbs.19642","article-title":"Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages","volume":"13","author":"Cheng","year":"2017","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105234_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6272498","article-title":"Tumor-derived exosomes in immunosuppression and immunotherapy","volume":"2020","author":"Olejarz","year":"2020","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib135","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.18632\/oncotarget.20812","article-title":"Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105234_bib136","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1038\/s41467-025-64172-w","article-title":"Dendritic cell progenitors engineered to express extracellular-vesicle\u2013internalizing receptors enhance cancer immunotherapy in mouse models","volume":"16","author":"Ghasemi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105234_bib137","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tranon.2018.01.001","article-title":"Dendritic cells pulsed with exosomes in combination with PD-1 antibody increase the efficacy of sorafenib in hepatocellular carcinoma model","volume":"11","author":"Shi","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib138","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/jcp.30645","article-title":"Tumor-derived exosomal PD-L1 in progression of cancer and immunotherapy","volume":"237","author":"Rasihashemi","year":"2022","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib139","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1703449","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology","volume":"9","author":"Vanmeerbeek","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10238-025-01659-2","article-title":"Exosome-based immunotherapy in hepatocellular carcinoma","volume":"25","author":"Liu","year":"2025","journal-title":"Clin. Exp. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500766","article-title":"Biomimetic delivery of cisplatin for efficient immunotherapy of gasdermin e-positive hepatocellular carcinoma via a Pt concentration-dependent minimalist pyroptosis strategy","volume":"14","author":"Huang","year":"2025","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.critrevonc.2026.105234_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47070525","article-title":"Targeting exosomal PD-L1 as a new frontier in cancer immunotherapy","volume":"47","author":"Dragu","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib143","article-title":"Enhancing chemotherapy-related immune responses via bioorthogonal metabolic engineering-driven tumor exosomes elimination","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.critrevonc.2026.105234_bib144","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-025-03403-w","article-title":"Harnessing engineered extracellular vesicles for enhanced therapeutic efficacy: advancements in cancer immunotherapy","volume":"44","author":"Gong","year":"2025","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105234_bib145","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2147\/IJN.S497510","article-title":"Overcoming biological barriers in cancer therapy: cell membrane-based nanocarrier strategies for precision delivery","volume":"20","author":"Li","year":"2025","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.critrevonc.2026.105234_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.574007","article-title":"Extracellular vesicles-mimetic encapsulation improves oncolytic viro-immunotherapy in tumors with low coxsackie and adenovirus receptor","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105234_bib147","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep4.1311","article-title":"Extracellular vesicle-based therapeutic targeting of \u03b2-catenin to modulate anticancer immune responses in hepatocellular cancer","volume":"3","author":"Matsuda","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.critrevonc.2026.105234_bib148","article-title":"In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence","volume":"6","author":"Guo","year":"2025","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.critrevonc.2026.105234_bib149","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11033-024-10157-9","article-title":"Exosome-driven nano-immunotherapy: revolutionizing colorectal cancer treatment","volume":"52","author":"Lahouty","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105234_bib150","article-title":"Carrier-free nanoparticles based on natural products trigger dual \u201csynergy and attenuation\u201d for enhanced phototherapy of liver cancer","volume":"35","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.critrevonc.2026.105234_bib151","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1097\/JS9.0000000000002361","article-title":"Nanosecond pulsed electric field ablation as first-line curative therapy for hepatocellular carcinoma in high-risk locations a prospective multicenter","volume":"111","author":"Xu","year":"2025","journal-title":"Int J. Surg."},{"key":"10.1016\/j.critrevonc.2026.105234_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.09.015","article-title":"Blocking exposed PD-L1 elicited by nanosecond pulsed electric field reverses dysfunction of CD8(+) T cells in liver cancer","volume":"495","author":"Qian","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105234_bib153","doi-asserted-by":"crossref","first-page":"32818","DOI":"10.1021\/acsnano.4c11257","article-title":"Dual-synergistic nanomodulator alleviates exosomal PD-L1 expression enabling exhausted cytotoxic T lymphocytes rejuvenation for potentiated iRFA-treated hepatocellular carcinoma immunotherapy","volume":"18","author":"Zhu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105234_bib154","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2026.105234_bib155","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1038\/s41467-025-63718-2","article-title":"Engineered exosomes with Kras(G12D) specific siRNA in pancreatic cancer: a phase I study with immunological correlates","volume":"16","author":"Kalluri","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:36:10Z","timestamp":1778481370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":155,"alternative-id":["S1040842826001216"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105234","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between exosomes and the PD-1\/PD-L1 axis in hepatocellular carcinoma: Implications for immune escape and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105234"}}